AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ANGIODYNAMICS INC Director's Dealing 2024

Mar 4, 2024

32939_dirs_2024-03-04_00bca09a-5067-48be-ba56-7d1af946b8f4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANGIODYNAMICS INC (ANGO)
CIK: 0001275187
Period of Report: 2024-02-29

Reporting Person: Trowbridge Stephen A (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-29	Common Stock	A	1927	$4.67	Acquired	128901	Direct

Footnotes

F1: These shares were acquired under the AngioDynamics, Inc. Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).